Trial Profile
A Long-Term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors. A Retrospective Follow-up Assessment to F7HAEM/USA/3/USA and F7HAEM/USA/4/USA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2024
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemophilia
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 15 May 2015 New trial record